|
|
Bristol-Myers Squibb Company today announced new data from the E.A.R.L.Y. study (ETV-079) Saturday, April 26, 2008 (118 reads)
Bristol-Myers Squibb Company today announced new data from the E.A.R.L.Y. study (ETV-079), in which treatment of antiviral-naïve adult chronic hepatitis B patients with BARACLUDE® (entecavir) resulted in greater long-term viral load reduction than adefovir at 96 weeks -- consistent with earlier 12-week results (primary endpoint). |
|
|
Fluoride Is Damaging Teeth Friday, April 25, 2008 (234 reads)
Many children risk dental fluorois from brushing twice a day with fluoridated toothpaste before factoring in fluoride in water, supplements, foods and beverages, according to the NYS Dental Journal. |
|
|
Important Progress Toward Control of Hepatitis B and C Friday, April 25, 2008 (128 reads)
Positive Tests Results for New Drugs Against Hepatitis C Improved Screening for Hepatitis C Reflects Physicians' Optimism New Drugs Effective Against Hepatitis B, But Patient Selection Necessary. |
|
|
World Nomads & BUPA Doing " The Great Walk to Beijing" for Cancer Friday, April 25, 2008 (131 reads)
Leading online travel insurance provider, WorldNomads.com, and leading health insurance provider, BUPA International, have come together to become corporate partners of the Olivia Newton - John cancer charity event "The Great Walk to Beijing". |
|
|
|
|
Lactagen®, A One-Time Solution For Lactose Intolerance, Featured In Today's Dietician Magazine Friday, April 25, 2008 (148 reads)
Today's Dietitian, the magazine for nutrition professionals, features an article about the all-natural, one-time solution for lactose intolerance, Lactagen in their April 2008 issue. Today's Dietitian is a magazine that features timely, informative, and award-winning articles on a wide range of health, nutrition, and fitness topics and is read by over 110,000 registered dietitians each month. |
|
|
Uniting to Fight Malaria Around the World Friday, April 25, 2008 (124 reads)
Today, on World Malaria Day, the American Red Cross is joining with its partners to raise awareness and encourage a robust global response to this deadly disease. |
|
|
|
|
|
|
 |
|